Phase 3 Coronary atherosclerosis Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial Infarction
Coronary Artery DiseaseAcute Myocardial Infarction (AMI)Coronary Atherosclerosis of Native Coronary Artery
ECRI bv332 enrolled1 locationNCT07276282
Recruiting
Phase 2Phase 3
Do stAtins faVourably modify atherosclerotIc plaque in patients with differeNt levels of polygenic Cardiovascular (CV) rIsk?
Coronary atherosclerosisPolygenic risk
Monash University600 enrolled6 locationsACTRN12620001166965
Not Yet Recruiting
Phase 3
Coronary Atherosclerosis Progression with Testosterone InterVEntion (CAPTIVE)
Coronary atherosclerosisCoronary atheroma
The University of Western Australia558 enrolled1 locationACTRN12620000100998